# Amgen Inc. (AMGN) — Q3-2024 Earnings Results

**Report date:** 2024-10-30 (after market close)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/AMGN/earnings/Q3-2024

## Post-Earnings Brief

### Headline

Amgen Beats on EPS, Stock Down 0.15%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $5.58 | N/A | +9.22% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management expressed confidence in the company's strategic direction despite not providing specific guidance. They noted positive trends in product demand.

**Key quotes:**

> Management highlighted strong performance in key therapeutic areas.

> They emphasized ongoing commitment to innovation and pipeline development.

### Guidance Changes

No forward guidance was provided in this earnings report.

### What It Means

Amgen's earnings report showed a positive surprise in EPS, indicating better-than-expected profitability. However, the stock dipped slightly by 0.15%, suggesting that investors may have been looking for more comprehensive revenue details or guidance. The lack of revenue data and future guidance may have contributed to the muted stock reaction.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/AMGN/earnings/Q3-2024_